A detailed history of Bank Of America Corp transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Bank Of America Corp holds 10,192 shares of CNTX stock, worth $15,491. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,192
Previous 10,776 5.42%
Holding current value
$15,491
Previous $21,000 9.52%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.79 - $2.66 $1,045 - $1,553
-584 Reduced 5.42%
10,192 $19,000
Q2 2024

Aug 14, 2024

BUY
$1.24 - $2.19 $13,362 - $23,599
10,776 New
10,776 $21,000
Q4 2023

Feb 14, 2024

BUY
$0.79 - $1.41 $7 - $12
9 Added 9.0%
109 $0
Q1 2023

May 12, 2023

SELL
$0.56 - $1.06 $9 - $18
-17 Reduced 14.53%
100 $0
Q4 2022

Feb 10, 2023

BUY
$0.61 - $1.42 $71 - $166
117 New
117 $0

Others Institutions Holding CNTX

About Context Therapeutics Inc.


  • Ticker CNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,966,100
  • Market Cap $24.3M
  • Description
  • Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...
More about CNTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.